Back

Reply to ‘Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort’

European Heart Journal

16 July 2018
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HEART FAILURE Chronic Heart Failure PREVENTIVE CARDIOLOGY Risk Factors and Prevention VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease Pharmacology and Pharmacotherapy

Contributors

Denise Hilfiker-Kleiner
Denise Hilfiker-Kleiner

Author

Hannover Medical School Hannover , Germany

Karen Sliwa
Karen Sliwa

Author

Johann Bauersachs
Johann Bauersachs

Author

You may be interested in
thumbnail
Congress Presentation
Bromocriptine treatment and outcome in patients with peripartum cardiomyopathy: the EORP PPCM registry
2 September 2024
thumbnail
Congress Presentation
Peripartum cardiomyopathy
21 May 2023
thumbnail
Congress Session
Heart failure in young women
17 May 2025
thumbnail
Congress Presentation
Global prevalence of mortality and LV recovery in women with PPCM - a systematic review and meta-analysis.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources